Sector: Pharmaceuticals & Biotechnology

Mid Cap

Corona Remedies Share Price

CORONA

₹2,027.20

47.80(2.41%)

9th Jul 2026 | 3:28 PM

NSE : CORONA

Open Free Demat Account

Corona Remedies Performance

Price Movement

₹2027.20

₹1984.90

₹2046.10

↘ Today's Low↗ Today's High

1 Year Performance

₹2027.20

₹1336.60

₹2100.70

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹2,046.10

Low₹1,984.90

Open at₹1,985.00

Prev Close₹1,979.40

Volumes11.37 K

Avg Price₹2,022.23

Lower Circuit₹1,583.60

Upper Circuit₹2,375.20

Historical Performance

3M High₹2,100.70

3M Low₹1,372.30

1 Yr High₹2,100.70

1 Yr Low₹1,336.60

3 Yr High₹2,100.70

3 Yr Low₹1,336.60

5 Yr High₹2,100.70

5 Yr Low₹1,336.60

Summary

As of 09-07-2026 18:41, Corona Remedies Ltd. share price today is ₹0, with a change of ₹-1979.40 (-100.00%) from the previous close of ₹1979.4. The stock opened at ₹1985 and traded between ₹1984.9 and ₹2046.1, with a total traded volume of 11366 shares. The company has a market capitalization of ₹12106 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹2100.7 and ₹1336.6, respectively.

Corona Remedies Ltd. valuation metrics include a P/E ratio of 65.4, EPS of ₹30.27, and book value of ₹16.20. Profitability indicators show ROE of 24.78% along with a dividend yield of 0.5%. Corona Remedies Ltd. has reported revenue of ₹1403.18 Cr and net profit of ₹185.12 Cr.

Corona Remedies Ltd. technical indicators include Day RSI at 63.52, Day MFI at 66.56, Day ADX at 47.23. Additional indicators include Commodity Channel Index (CCI) at 69.6 and Williams %R at -36.58. Momentum indicators show Day MACD at 72.69, Day MACD Signal Line at 66.26, DayATR at 78.06. Rate of Change indicators for Corona Remedies Ltd. include ROC125 at 41.14 and ROC21 at 13.72.

Exponential moving averages include EMA5 at ₹1987.7, EMA10 at ₹1962.8, EMA12 at ₹1950.4, EMA20 at ₹1905, EMA26 at ₹1877.7, EMA50 at ₹1800.7, EMA100 at ₹1695. Simple moving averages include SMA5 at ₹2003.8, SMA10 at ₹1975.3, SMA20 at ₹1882, SMA30 at ₹1823.6, SMA50 at ₹1785.4, SMA100 at ₹1685.4.

Support levels for Corona Remedies are placed at First Support ₹1950.70, Second Support ₹1922.00, Third Support ₹1883.90. Resistance levels are seen at First Resistance ₹2017.50, Second Resistance ₹2055.60, Third Resistance ₹2084.30. Corona Remedies Ltd. shareholding pattern shows promoter holding at 69%, FII holding at 2.25%, DII holding at 0%, public holding at 21.75%.

Corona Remedies Fundamentals

Market Cap

High in industry

12,106 Cr.

PE Ratio (TTM)

High in industry

65.40

Dividend Yield

Above industry Median

0.50

Net Profit TTM

185.12

Net Profit Growth

185.12

PEG Ratio

ROE

0.6% incr over last year

24.78

Operating Revenue TTM

1,403.18

Operating Revenue Growth

Book Value

High in industry

16.20

MFI

MFI is mid-range

66.56

RSI

RSI is mid-range

63.52

EPS (TTM)

30.27

Debt to Equity

0.19

Face Value

Operating Profit Margin Qtr.

20.75

Operating Profit Qtr.

62.02

Net Profit Qtr.

45.33

Operating Revenue Qtr.

353.09

PB Ratio

16.20

Corona Remedies Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	353.09	342.42	361.13	346.54	293.69
Operating Expense	291.07	259.26	282.66	276.76	239.47
Operating Profit	62.02	83.16	78.47	69.78	54.22
Depreciation	10.29	9.45	9.20	8.92	10.04
Interest	1.38	1.66	1.93	1.99	2.20
Tax	9.41	13.94	17.46	14.49	12.06
Net Profit	45.05	41.25	52.15	46.40	31.34

Corona Remedies Technicals

Corona Remedies Ltd. EMA & SMA

₹2027.20

38.40 (1.93%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1987.7

Day EMA10 ₹1962.8

Day EMA12 ₹1950.4

Day EMA20 ₹1905

Day EMA26 ₹1877.7

Day EMA50 ₹1800.7

Day EMA100 ₹1695

Corona Remedies Support and Resistance

Resistance

First Resistance₹2017.50

Second Resistance₹2055.60

Third Resistance₹2084.30

Support

First Support₹1950.70

Second Support₹1922.00

Third Support₹1883.90

Technical Indicators

Day RSI63.52

Day MFI66.56

Day ADX47.23

Day Commodity Channel Index69.60

William-36.58

Day MACD72.69

Day MACD Signal Line66.26

Day ATR78.06

Day ROC12541.14

Day ROC2113.72

Corona Remedies Shareholding Pattern

Held By	Dec 2025	Mar 2026
Promoter	69	69
FII	1.8	2.2
DII	6.8	7.1
Public	22.4	21.8

Corona Remedies Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	5.95 K	12.65 K	47.03%
Week	16.29 K	34.5 K	47.22%
1 Month	32.66 K	74.8 K	43.66%
6 Month	25.73 K	54 K	47.66%

Corona Remedies SWOT Analysis

Strengths21

Weakness7

Opportunity4

Threats2

Benjamin Graham Value Screen

Companies with 10% increase in share price over three months, with rising net profit growth

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Expensive Performers (DVM)

Annual Profit Growth higher than Sector Profit Growth

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

Negative to Positive growth in Sales and Profit with Strong Price momentum

RSI indicating price strength

Stocks Outperforming their Industry Price Change in the Quarter

Corona Remedies Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
19 Jun, 2026	10	FINAL	19 Jun, 2026	Equity Share

Corona Remedies Stock Comparison

Financials	Sudeep Pharma Ltd.	Syngene International Ltd.	Alembic Pharmaceuticals Ltd.	Sun Pharma Advanced Research Company Ltd.	Strides Pharma Science Ltd.
Price (₹)	₹807	₹415.85	₹816	₹278.05	₹1,072
% Change	0.84%	1.03%	0.58%	2.99%	-0.81%
Revenue TTM (₹ Cr)	₹642.26	₹3,738.70	₹7,344.90	₹1,879.17	₹4,858.68
Net Profit TTM (₹ Cr)	₹172.89	₹316.70	₹674.76	₹1,553.20	₹556.19
PE TTM	52.30	52.50	23.60	5.60	17.90
1 Year Return	34.96	-34.94	-18.91	72.54	24.86
ROCE	24.22	9.74	13.84	112.89	21.66

Similar Stocks

FDC

FDC Ltd.

₹ 431.70

+1.96%

SHILPAMED

Shilpa Medicare Ltd.

₹ 624.80

+4.95%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 972.00

+0.13%

NATCOPHARM

Natco Pharma Ltd.

₹ 961.55

-0.49%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 2626.00

+3.86%

MARKSANS

Marksans Pharma Ltd.

₹ 278.80

+5.83%

ORCHPHARMA

Orchid Pharma Ltd.

₹ 1050.00

+4.76%

BLISSGVS

Bliss GVS Pharma Ltd.

₹ 526.90

+2.72%

SANOFI

Sanofi India Ltd.

₹ 3349.00

-0.96%

PGHL

Procter & Gamble Health Ltd.

₹ 6600.00

+5.39%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 590.00

+4.71%

SENORES

Senores Pharmaceuticals Ltd.

₹ 1418.10

+0.59%

ONESOURCE

OneSource Specialty Pharma Ltd.

₹ 1625.00

+0.81%

SANOFICONR

Sanofi Consumer Healthcare India Ltd.

₹ 4508.00

-0.69%

AKUMS

Akums Drugs & Pharmaceuticals Ltd.

₹ 660.00

+1.95%

INNOVACAP

Innova Captab Ltd.

₹ 992.00

+0.93%

BLUEJET

Blue Jet Healthcare Ltd

₹ 575.75

+2.32%

CONCORDBIO

Concord Biotech Ltd.

₹ 1311.20

+4.08%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 704.00

+2.59%

SUPRIYA

Supriya Lifescience Ltd.

₹ 876.50

+1.72%

ALIVUS

Alivus Life Sciences Ltd.

₹ 1145.90

+1.40%

COHANCE

Cohance Lifesciences Ltd.

₹ 441.00

+2.37%

ERIS

Eris Lifesciences Ltd.

₹ 1430.00

+0.99%

FAQ's on CORONA

What is the current share price of Corona Remedies Ltd.?

As of 8 July 2026 at 10:01 AM, the share price for Corona Remedies Ltd. is ₹ 2027.2 on the NSE and ₹ 2022.15 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Corona Remedies Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 8 July 2026, the market cap for Corona Remedies Ltd. is approximately ₹ 12106 Cr.

What are the PE and PB ratios for Corona Remedies Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Corona Remedies Ltd. is 65.4, and the Price-to-Book (PB) ratio is 16.2.

What is the 52-Week High and Low for Corona Remedies Ltd.?

Over the past 52 weeks, the highest price reached by Corona Remedies Ltd. shares was ₹ 2100.7, and the lowest price was ₹ 1336.6.

What is the current dividend yield for Corona Remedies Ltd.?

As of 8 July 2026, the dividend yield for Corona Remedies Ltd. is 0.5%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Corona Remedies Ltd.?

Significant shareholdings in Corona Remedies Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Corona Remedies Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Corona Remedies Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Corona Remedies Ltd.?

Corona Remedies Ltd. last declared a FINAL dividend of ₹ 10 per share for the financial period ending 2026. The record date was set as 2026-06-19, and the payment was/is scheduled around 2026-06-19. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy